Homebiotech

biotech

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026

biotech

Rare oral cancer has distinct genetic profile

Jim Cornall - May 26, 2026

biotech

New tool decodes structures and motifs of RNA

Jim Cornall - May 26, 2026

biotech

Elite immune cells lead fight against multiple myeloma

Jim Cornall - May 25, 2026

biotech

Approval for prostate cancer treatment

Jim Cornall - March 12, 2026

biotech

Approval for atopic dermatitis treatment

Jim Cornall - March 11, 2026

biotech

FDA Breakthrough Therapy Designation for Glanzmann Thrombasthenia drug

Jim Cornall - March 11, 2026

biotech

New company targets dry eye disease with first-in-class therapy

Jim Cornall - March 11, 2026

biotech

Collaboration to advance novel combination therapy for glioblastoma

Jim Cornall - March 10, 2026

biotech

Study shows AI boosts breast cancer detection by more than 10 percent

Jim Cornall - March 10, 2026

biotech

First reliable biomarker test for early kidney transplant rejection detection in living-donor recipients

Jim Cornall - March 10, 2026

biotech

Approval for drug to treat advanced squamous cell carcinoma of the anal canal

Jim Cornall - March 9, 2026

1...161718...78 Page 17 of 78

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026 0

OSE Immunotherapeutics SA has announced the release of the abstract selected for an oral presentation at the upcoming ASCO 2026 annual meeting, unveiling topline...

Rare oral cancer has distinct genetic profile

biotech Jim Cornall - May 26, 2026 0

New tool decodes structures and motifs of RNA

biotech Jim Cornall - May 26, 2026 0

Elite immune cells lead fight against multiple myeloma

biotech Jim Cornall - May 25, 2026 0

National framework to strengthen UK advanced therapy clinical trials

biotech Jim Cornall - May 25, 2026 0